296 related articles for article (PubMed ID: 27764700)
1. Current Evidence and Future Perspectives on HuR and Breast Cancer Development, Prognosis, and Treatment.
Kotta-Loizou I; Vasilopoulos SN; Coutts RH; Theocharis S
Neoplasia; 2016 Nov; 18(11):674-688. PubMed ID: 27764700
[TBL] [Abstract][Full Text] [Related]
2. Clinical Significance and Biological Role of HuR in Head and Neck Carcinomas.
Levidou G; Kotta-Loizou I; Tasoulas J; Papadopoulos T; Theocharis S
Dis Markers; 2018; 2018():4020937. PubMed ID: 29619127
[TBL] [Abstract][Full Text] [Related]
3. An RNA-Binding Protein, Hu-antigen R, in Pancreatic Cancer Epithelial to Mesenchymal Transition, Metastasis, and Cancer Stem Cells.
Dong R; Chen P; Polireddy K; Wu X; Wang T; Ramesh R; Dixon DA; Xu L; Aubé J; Chen Q
Mol Cancer Ther; 2020 Nov; 19(11):2267-2277. PubMed ID: 32879054
[TBL] [Abstract][Full Text] [Related]
4. Targeting the interaction between RNA-binding protein HuR and FOXQ1 suppresses breast cancer invasion and metastasis.
Wu X; Gardashova G; Lan L; Han S; Zhong C; Marquez RT; Wei L; Wood S; Roy S; Gowthaman R; Karanicolas J; Gao FP; Dixon DA; Welch DR; Li L; Ji M; Aubé J; Xu L
Commun Biol; 2020 Apr; 3(1):193. PubMed ID: 32332873
[TBL] [Abstract][Full Text] [Related]
5. The RNA-binding protein HuR inhibits expression of CCL5 and limits recruitment of macrophages into tumors.
Brauß TF; Winslow S; Lampe S; Scholz A; Weigert A; Dehne N; von Stedingk K; Schmid T; Brüne B
Mol Carcinog; 2017 Dec; 56(12):2620-2629. PubMed ID: 28731284
[TBL] [Abstract][Full Text] [Related]
6. Multiple functions of HuR in urinary tumors.
Zhang F; Cai Z; Lv H; Li W; Liang M; Wei X; Zhou F
J Cancer Res Clin Oncol; 2019 Jan; 145(1):11-18. PubMed ID: 30370480
[TBL] [Abstract][Full Text] [Related]
7. Cytoplasmic overexpression of RNA-binding protein HuR is a marker of poor prognosis in meningioma, and HuR knockdown decreases meningioma cell growth and resistance to hypoxia.
Gauchotte G; Hergalant S; Vigouroux C; Casse JM; Houlgatte R; Kaoma T; Helle D; Brochin L; Rech F; Peyre M; Labrousse F; Vallar L; Guéant JL; Vignaud JM; Battaglia-Hsu SF
J Pathol; 2017 Aug; 242(4):421-434. PubMed ID: 28493484
[TBL] [Abstract][Full Text] [Related]
8. HuR, a key post-transcriptional regulator, and its implication in progression of breast cancer.
Yuan Z; Sanders AJ; Ye L; Jiang WG
Histol Histopathol; 2010 Oct; 25(10):1331-40. PubMed ID: 20712017
[TBL] [Abstract][Full Text] [Related]
9. Human antigen R and drug resistance in tumors.
Zhou F; Zhang F; Zhou C; Liang M; Cai Z; Lv H; Li W; Wei X
Invest New Drugs; 2019 Oct; 37(5):1107-1116. PubMed ID: 30612309
[TBL] [Abstract][Full Text] [Related]
10. HuR promotes breast cancer cell proliferation and survival via binding to CDK3 mRNA.
Zhang Z; Huang A; Zhang A; Zhou C
Biomed Pharmacother; 2017 Jul; 91():788-795. PubMed ID: 28501005
[TBL] [Abstract][Full Text] [Related]
11. Multiple functions of the RNA-binding protein HuR in cancer progression, treatment responses and prognosis.
Wang J; Guo Y; Chu H; Guan Y; Bi J; Wang B
Int J Mol Sci; 2013 May; 14(5):10015-41. PubMed ID: 23665903
[TBL] [Abstract][Full Text] [Related]
12. The RNA Binding Protein HuR: A Promising Drug Target for Anticancer Therapy.
Wu M; Tong CWS; Yan W; To KKW; Cho WCS
Curr Cancer Drug Targets; 2019; 19(5):382-399. PubMed ID: 30381077
[TBL] [Abstract][Full Text] [Related]
13. HuR-targeted small molecule inhibitor exhibits cytotoxicity towards human lung cancer cells.
Muralidharan R; Mehta M; Ahmed R; Roy S; Xu L; Aubé J; Chen A; Zhao YD; Herman T; Ramesh R; Munshi A
Sci Rep; 2017 Aug; 7(1):9694. PubMed ID: 28855578
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of novel small molecule disruptors of HuR-mRNA interaction.
Wu X; Lan L; Wilson DM; Marquez RT; Tsao WC; Gao P; Roy A; Turner BA; McDonald P; Tunge JA; Rogers SA; Dixon DA; Aubé J; Xu L
ACS Chem Biol; 2015 Jun; 10(6):1476-84. PubMed ID: 25750985
[TBL] [Abstract][Full Text] [Related]
15. Posttranscriptional Regulation of the Inflammatory Marker C-Reactive Protein by the RNA-Binding Protein HuR and MicroRNA 637.
Kim Y; Noren Hooten N; Dluzen DF; Martindale JL; Gorospe M; Evans MK
Mol Cell Biol; 2015 Dec; 35(24):4212-21. PubMed ID: 26438598
[TBL] [Abstract][Full Text] [Related]
16. Dual mechanisms of action of the RNA-binding protein human antigen R explains its regulatory effect on melanoma cell migration.
Moradi F; Berglund P; Linnskog R; Leandersson K; Andersson T; Prasad CP
Transl Res; 2016 Jun; 172():45-60. PubMed ID: 26970271
[TBL] [Abstract][Full Text] [Related]
17. Identification of NOD2 as a novel target of RNA-binding protein HuR: evidence from NADPH oxidase-mediated HuR signaling in diabetic nephropathy.
Shang J; Wan Q; Wang X; Duan Y; Wang Z; Wei X; Zhang Y; Wang H; Wang R; Yi F
Free Radic Biol Med; 2015 Feb; 79():217-27. PubMed ID: 25528059
[TBL] [Abstract][Full Text] [Related]
18. Hu antigen R (HuR) multimerization contributes to glioma disease progression.
Filippova N; Yang X; Ananthan S; Sorochinsky A; Hackney JR; Gentry Z; Bae S; King P; Nabors LB
J Biol Chem; 2017 Oct; 292(41):16999-17010. PubMed ID: 28790173
[TBL] [Abstract][Full Text] [Related]
19. Silencing of the mRNA-binding protein HuR increases the sensitivity of colorectal cancer cells to ionizing radiation through upregulation of caspase-2.
Badawi A; Hehlgans S; Pfeilschifter J; Rödel F; Eberhardt W
Cancer Lett; 2017 May; 393():103-112. PubMed ID: 28219770
[TBL] [Abstract][Full Text] [Related]
20. ERK8 is a novel HuR kinase that regulates tumour suppressor PDCD4 through a miR-21 dependent mechanism.
Liwak-Muir U; Dobson CC; Naing T; Wylie Q; Chehade L; Baird SD; Chakraborty PK; Holcik M
Oncotarget; 2016 Jan; 7(2):1439-50. PubMed ID: 26595526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
